» Articles » PMID: 38383871

Central Artery Hemodynamics in Angiotensin II-Induced Hypertension and Effects of Anesthesia

Overview
Journal Ann Biomed Eng
Date 2024 Feb 22
PMID 38383871
Authors
Affiliations
Soon will be listed here.
Abstract

Systemic hypertension is a strong risk factor for cardiovascular, neurovascular, and renovascular diseases. Central artery stiffness is both an initiator and indicator of hypertension, thus revealing a critical relationship between the wall mechanics and hemodynamics. Mice have emerged as a critical animal model for studying effects of hypertension and much has been learned. Regardless of the specific mouse model, data on changes in cardiac function and hemodynamics are necessarily measured under anesthesia. Here, we present a new experimental-computational workflow to estimate awake cardiovascular conditions from anesthetized data, which was then used to quantify effects of chronic angiotensin II-induced hypertension relative to normotension in wild-type mice. We found that isoflurane anesthesia had a greater impact on depressing hemodynamics in angiotensin II-infused mice than in controls, which led to unexpected results when comparing anesthetized results between the two groups of mice. Through comparison of the awake simulations, however, in vivo relevant effects of angiotensin II-infusion on global and regional vascular structure, properties, and hemodynamics were found to be qualitatively consistent with expectations. Specifically, we found an increased in vivo vascular stiffness in the descending thoracic aorta and suprarenal abdominal aorta, leading to increases in pulse pressure in the distal aorta. These insights allow characterization of the impact of regionally varying vascular remodeling on hemodynamics and mouse-to-mouse variations due to induced hypertension.

References
1.
Tan T, Gao X, Krawczyszyn M, Feng X, Kiriazis H, Dart A . Assessment of cardiac function by echocardiography in conscious and anesthetized mice: importance of the autonomic nervous system and disease state. J Cardiovasc Pharmacol. 2003; 42(2):182-90. DOI: 10.1097/00005344-200308000-00005. View

2.
Ullman J, Hargestam R, Lindahl S, Chan S, Eriksson S, Rundgren M . Circulatory effects of angiotensin II during anaesthesia, evaluated by real-time spectral analysis. Acta Anaesthesiol Scand. 2003; 47(5):532-40. DOI: 10.1034/j.1399-6576.2003.00114.x. View

3.
Samain E, Bouillier H, Rucker-Martin C, Mazoit J, Marty J, Renaud J . Isoflurane alters angiotensin II-induced Ca2+ mobilization in aortic smooth muscle cells from hypertensive rats: implication of cytoskeleton. Anesthesiology. 2002; 97(3):642-51. DOI: 10.1097/00000542-200209000-00019. View

4.
Takuma S, Suehiro K, Cardinale C, Hozumi T, Yano H, Shimizu J . Anesthetic inhibition in ischemic and nonischemic murine heart: comparison with conscious echocardiographic approach. Am J Physiol Heart Circ Physiol. 2001; 280(5):H2364-70. DOI: 10.1152/ajpheart.2001.280.5.H2364. View

5.
Aslanidou L, Trachet B, Reymond P, Fraga-Silva R, Segers P, Stergiopulos N . A 1D model of the arterial circulation in mice. ALTEX. 2015; 33(1):13-28. DOI: 10.14573/altex.1507071. View